Atlantic Equities analyst James Mainwaring upgrades Abbott Laboratories (NYSE:ABT) from Neutral to Overweight and announces $144 price target.
Where Sportradar Gr Stands With Analysts
Over the past 3 months, 8 analysts have published their opinion on Sportradar Gr (NASDAQ:SRAD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
